echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Antitumor Therapy > SMO inhibitor’s application for marketing was given priority review by CDE for treatment of basal cell carcinoma

    SMO inhibitor’s application for marketing was given priority review by CDE for treatment of basal cell carcinoma

    • Last Update: 2021-03-19
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Today, Shanghai Jiyu Medicine/Sun Pharma’s application for the listing of Sonny Deji Phosphate Capsules (trade name: Odomzo) was included in the priority review by CDE and started to be publicized for use in adult patients with locally advanced basal cell carcinoma (BCC) recurring after surgery or radiotherapy.


    Sonidji Phosphate is an oral Smoothened (SMO) inhibitor developed by Novartis.


    stem cell

    Sony Deji phosphate as early as July 24, 2015 the US Food and Drug Administration Administration ( the FDA ) approved for marketing for the treatment of relapse after surgery or radiotherapy for locally advanced basal cell carcinoma, basal cell carcinoma or not surgery or radiation therapy.


    Manage FDA

    Odomzo’s FDA approval is based on a multi-center, double-blind, multi-cohort clinical study ((BOLT) in patients with locally advanced basal cell carcinoma (laBCC) (n=194) or metastatic basal cell carcinoma (mBCC) (n=36).


    Basal cell carcinoma (BCC) is a common skin cancer that accounts for 80% of all non-melanoma cases.


    Leave a message here
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.